Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers

被引:0
|
作者
Sijbesma, Eline [1 ]
Hallenbeck, Kenneth K. [2 ]
Leysen, Seppe [1 ]
De Vink, Pim J. [1 ]
Skóra, Lukasz [3 ]
Jahnke, Wolfgang [3 ]
Brunsveld, Luc [1 ]
Arkin, Michelle R. [2 ]
Ottmann, Christian [1 ,4 ]
机构
[1] Laboratory of Chemical Biology, Department of Biomedical Engineering, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven,5600 MB, Netherlands
[2] Department of Pharmaceutical Chemistry, Small Molecule Discovery Centre (SMDC), University of California, San Francisco,94143, United States
[3] Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel,CH-4056, Switzerland
[4] Department of Chemistry, University of Duisburg-Essen, Essen,47057, Germany
来源
Journal of the American Chemical Society | 2019年 / 141卷 / 08期
关键词
Breast Cancer - Drug discovery - Estrogen receptor - Fragment-based screenings - Protein-protein interactions - Screening techniques - Small molecules - X ray crystal structures;
D O I
暂无
中图分类号
学科分类号
摘要
Modulation of protein-protein interactions (PPIs) by small molecules has emerged as a valuable approach in drug discovery. Compared to direct inhibition, PPI stabilization is vastly underexplored but has strong advantages, including the ability to gain selectivity by targeting an interface formed only upon association of proteins. Here, we present the application of a site-directed screening technique based on disulfide trapping (tethering) to select for fragments that enhance the affinity between protein partners. We target the phosphorylation-dependent interaction between the hub protein 14-3-3σ and a peptide derived from Estrogen Receptor α (ERα), an important breast cancer target that is negatively regulated by 14-3-3σ. We identify orthosteric stabilizers that increase 14-3-3/ERα affinity up to 40-fold and propose the mechanism of stabilization based on X-ray crystal structures. These fragments already display partial selectivity toward ERα-like motifs over other representative 14-3-3 clients. This first of its kind study illustrates the potential of the tethering approach to overcome the hurdles in systematic PPI stabilizer discovery. © 2019 American Chemical Society.
引用
收藏
页码:3524 / 3531
相关论文
共 50 条
  • [1] Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers
    Sijbesma, Eline
    Hallenbeck, Kenneth K.
    Leysen, Seppe
    de Vink, Pim J.
    Skora, Lukasz
    Jahnke, Wolfgang
    Brunsyeld, Luc
    Arkin, Michelle R.
    Ottmann, Christian
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (08) : 3524 - 3531
  • [2] Fragment-based drug discovery and protein-protein interactions
    Turnbull, Andrew P.
    Boyd, Susan M.
    Walse, Bjorn
    RESEARCH AND REPORTS IN BIOCHEMISTRY, 2014, 4 : 13 - 26
  • [3] Targeting Protein-Protein Interactions and Fragment-Based Drug Discovery
    Valkov, Eugene
    Sharpe, Tim
    Marsh, May
    Greive, Sandra
    Hyvoenen, Marko
    FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 145 - 179
  • [4] Fragment-Based Stabilizers of Protein-Protein Interactions through Imine-Based Tethering
    Wolter, Madita
    Valenti, Dario
    Cossar, Peter J.
    Levy, Laura M.
    Hristeva, Stanimira
    Genski, Thorsten
    Hoffmann, Torsten
    Brunsveld, Luc
    Tzalis, Dimitrios
    Ottmann, Christian
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (48) : 21520 - 21524
  • [5] Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction
    Chen, Danqi
    Chen, Yuehong
    Lian, Fulin
    Chen, Liu
    Li, Yanlian
    Cao, Danyan
    Wang, Xin
    Chen, Lin
    Li, Jian
    Meng, Tao
    Huang, Min
    Geng, Meiyu
    Shen, Jingkang
    Zhang, Naixia
    Xiong, Bing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 597 - 609
  • [6] Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease
    Gable, Jonathan E.
    Lee, Gregory M.
    Acker, Timothy M.
    Hulce, Kaitlin R.
    Gonzalez, Eric R.
    Schweigler, Patrick
    Melkko, Samu
    Farady, Christopher J.
    Craik, Charles S.
    CHEMMEDCHEM, 2016, 11 (08) : 862 - 869
  • [7] Fragment-based drug discovery supports drugging 'undruggable' protein-protein interactions
    Wang, Zhi-Zheng
    Shi, Xing-Xing
    Huang, Guang-Yi
    Hao, Ge-Fei
    Yang, Guang-Fu
    TRENDS IN BIOCHEMICAL SCIENCES, 2023, 48 (06) : 539 - 552
  • [8] A Systematic Approach to the Discovery of Protein-Protein Interaction Stabilizers
    Kenanova, Dyana N.
    Visser, Emira J.
    Virta, Johanna M.
    Sijbesma, Eline
    Centorrino, Federica
    Vickery, Holly R.
    Zhong, Mengqi
    Neitz, R. Jeffrey
    Brunsveld, Luc
    Ottmann, Christian
    Arkin, Michelle R.
    ACS CENTRAL SCIENCE, 2023, 9 (05) : 937 - 946
  • [9] SITE-DIRECTED MUTAGENESIS IN ANALYSIS OF PROTEIN-PROTEIN INTERACTIONS
    KAMMORGAN, LNW
    LAVOIE, TB
    SMITHGILL, SJ
    KIRSCH, JF
    MOLECULAR EVOLUTION: PRODUCING THE BIOCHEMICAL DATA, 1993, 224 : 503 - 516
  • [10] Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly
    Erlanson, DA
    Hansen, SK
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2004, 8 (04) : 399 - 406